Targeting recovery from acute kidney injury: executive summary from the round table conference at the 19th International Conference on Continuous Renal Replacement Therapies (Manchester Grand Hyatt, San Diego, Calif., USA, March 2-3, 2014).

12 Bonventre JV: Maladaptive proximal tubule repair: cell cycle arrest. Nephron Clin Pract 2014;127:61–64. 13 Portilla D: Apoptosis, fibrosis and senescence. Nephron Clin Pract 2014;127:65–69. 14 Andringa KK, Agarwal A: Role of hypoxia-inducible factors in acute kidney injury. Nephron Clin Pract 2014;127:70–74. 15 Fleig SV, Humphreys BD: Rationale of mesenchymal stem cell therapy in kidney injury. Nephron Clin Pract 2014;127:75–80. 16 Kellum JA: How can we define recovery after acute kidney injury? Considerations from epidemiology and clinical trial design. Nephron Clin Pract 2014;127:81–88. 17 Billings FT IV, Shaw AD: Clinical trial endpoints in acute kidney injury. Nephron Clin Pract 2014;127:89–93. 18 Sharma A, Mucino MJ, Ronco C: Renal functional reserve and renal recovery after acute kidney injury. Nephron Clin Pract 2014;127: 94–100. 19 Endre ZH: Recovery from acute kidney injury: the role of biomarkers. Nephron Clin Pract 2014;127:101–105. 20 Hundae A, McCullough PA: Cardiac and renal fibrosis in chronic cardiorenal syndromes. Nephron Clin Pract 2014;127:106–112. 21 Liu KD: Therapeutic strategies for clinical trials targeting renal recovery. Nephron Clin Pract 2014;127:113–116. Contributions of These Proceedings